Literature DB >> 6307526

The 34 kd pp60src substrate is located at the inner face of the plasma membrane.

M E Greenberg, G M Edelman.   

Abstract

The subcellular localization of the 34 kd protein substrate of the pp60src kinase was investigated by immunofluorescence microscopy and subcellular fractionation. When permeabilized fibroblasts were stained with a monoclonal anti-34 kd protein antibody, a diffuse reticular pattern was observed. The 34 kd protein was not exposed on the outside surface of the cell. Double immunofluorescence staining experiments established that the 34 kd protein distribution was similar to that of the membrane-associated protein alpha-spectrin. The 34 kd protein was found in cell sections to be concentrated along the cell edges. Taken together, these results suggested that the 34 kd pp60src substrate was associated with the inside surface of the plasma membrane. This conclusion was supported by subcellular fractionation experiments in which the 34 kd protein was observed to fractionate with the plasma membrane. These localization studies support further the hypothesis that many of the primary effects of the pp60src kinase occur at the plasma membrane.

Mesh:

Substances:

Year:  1983        PMID: 6307526     DOI: 10.1016/0092-8674(83)90019-3

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  43 in total

1.  Amino-terminal sequence of p36 and associated p10: identification of the site of tyrosine phosphorylation and homology with S-100.

Authors:  J R Glenney; B F Tack
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

2.  Two related but distinct forms of the Mr 36,000 tyrosine kinase substrate (calpactin) that interact with phospholipid and actin in a Ca2+-dependent manner.

Authors:  J Glenney
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

3.  Biochemical properties of p60v-src mutants that induce different cell transformation parameters.

Authors:  R Jove; E A Garber; H Iba; H Hanafusa
Journal:  J Virol       Date:  1986-12       Impact factor: 5.103

4.  Specific release of membrane-bound annexin II and cortical cytoskeletal elements by sequestration of membrane cholesterol.

Authors:  T Harder; R Kellner; R G Parton; J Gruenberg
Journal:  Mol Biol Cell       Date:  1997-03       Impact factor: 4.138

5.  Modification of annexin II expression in PC12 cell lines does not affect Ca(2+)-dependent exocytosis.

Authors:  M E Graham; V Gerke; R D Burgoyne
Journal:  Mol Biol Cell       Date:  1997-03       Impact factor: 4.138

6.  Synthesis of p36 and p35 is increased when U-937 cells differentiate in culture but expression is not inducible by glucocorticoids.

Authors:  C M Isacke; R A Lindberg; T Hunter
Journal:  Mol Cell Biol       Date:  1989-01       Impact factor: 4.272

7.  Regulation of calpactin I phospholipid binding by calpactin I light-chain binding and phosphorylation by p60v-src.

Authors:  M A Powell; J R Glenney
Journal:  Biochem J       Date:  1987-10-15       Impact factor: 3.857

8.  SIAH-1 promotes apoptosis and tumor suppression through a network involving the regulation of protein folding, unfolding, and trafficking: identification of common effectors with p53 and p21(Waf1).

Authors:  J P Roperch; F Lethrone; S Prieur; L Piouffre; D Israeli; M Tuynder; M Nemani; P Pasturaud; M C Gendron; J Dausset; M Oren; R B Amson; A Telerman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

9.  Isolation of a cDNA clone complementary to sequences for a 34-kilodalton protein which is a pp60v-src substrate.

Authors:  H G Tomasiewicz; R Cook-Deegan; D M Chikaraishi
Journal:  Mol Cell Biol       Date:  1984-09       Impact factor: 4.272

10.  Intranuclear appearance of the phosphorylated form of cytoskeleton-associated 350-kDa proteins in U1-ribonucleoprotein regions after growth stimulation of fibroblasts.

Authors:  C Sato; K Nishizawa; T Nakayama; K Nose; Y Takasaki; S Hirose; H Nakamura
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.